Pseudocontrols of random families with at least one affected proband case are equal to unscreened controls (i.e. population mean) as displayed for the allele frequency of single loci of different effect-size (first two rows) and the mean genetic liability ‫)ܩ(ܧ‬ (population mean equals 0) for variable heritability ℎ ଶ (bottom row) and different baseline population risk ‫.ܭ‬ The equivalence is exact and follows from the closed formulas provided in the R scripts, but is non-trivial to display in equations, because multiple sequential probabilities were needed to derive at the allele frequency and mean genetic liability in pseudocontrols. The equivalence can be understood intuitively by realizing that the non-transmitted alleles of random proband family are, in fact, part of the population background. Figure S3 . Power to detect a single SNP in trio-design and unscreened control studies, p=0.6
The power is displayed for a risk allele with frequency p=0.6, and results indicate that the conclusions do not depend on the allele frequency (noting that in Figure S2 The allele frequency in cases from trios with unaffected parents is displayed as the red dotted line, and the allele frequency in their pseudocontrols as the dotted blue line. To summarize: solid=no selection on parents; dotted=unaffected parents; grey=power; red=allele frequency case; blue=allele frequency pseudocontrol. Note that the grey lines overlap, i.e. selecting trios with unaffected parents does not increase power in pseudocontrol studies. Furthermore, note that for ‫ܭ‬ = 0.1 and ‫ܭ‬ = 0.5 the allele frequencies are lower in trios from unaffected parents, but this difference is proportional for cases and pseudocontrol resulting in no power-difference. Figure S7 . Power to detect a risk variant from screened vs. unscreened controls studies Power to detect a risk variant with risk allele frequency ‫‬ = 0.2 for 10,000 proband cases vs 10,000 screened controls (solid red line) and 10,000 proband cases vs respectively 10,000 unscreened controls (dotted line), 15,000 unscreened controls (short dashed), 20,000 unscreened controls (long dashed), and 50,000 unscreened controls (dot-dashed). Table S1 . Values of the Haseman Elston cross-product accounting for falsely classified controls
To adjust the transformation from the heritability on the observed scale ℎ ଶ to the liability scale ℎ ଶ for a
of falsely classified controls, we closely followed the derivations of Golan et al, which we recommend for further reading (paragraphs 1.2 and 1.3 of their Supplemental Materials). 1 The adjusted expected values of the cross-product ܼ used for Haseman Elstonregression follow from considering the true disease status ‫ݕ‬ ௧௨ and assumed disease status ‫ݕ‬ ௦௦௨ௗ
with probabilities
The 9 possible pairs, their probabilities ℙ and values of cross-product ܼ are displayed in the Table. The expected values of ॱ[ܼ ‫ݕ|‬ ௧௨, , ‫ݕ‬ ௧௨, ] follow as: e. Defining disease status ‫ݕ‬ = 1 for those with ݈ > ܶ with ܶ the liability threshold corresponding to a proportion of ‫ܭ‬ cases 3.
Step 2 was repeated until we obtained 2,000 cases, an additional ‫ܨ‬ * 2,000 cases which we labeled as controls, and (1 − ‫)ܨ‬ * 2,000 true controls. The cases and controls were saved in a single ped-file.
4. Plink was used to transform the ped-file to a bim-file, 2 and GCTA 3 to estimate the genetic relationship matrix and to perform cross-product Haseman-Elston regression with the "--HEreg" option yielding ℎ ଶ .
5. Steps 1-4 were repeated 10 times. The mean of these 10 point-estimates of the SNPheritability are displays, as well as their standard error (SE) estimated as their standard deviation divided by √10.
6. The mean ℎ ଶ was, first, transformed to the liability scale assuming ‫ܨ‬ = 0 (i.e. with Equation 2, Legend to Table S3 .
We validated the analytical estimations (see Supplemental Methods) of the mean genetic liabilities ‫)ܩ(ܧ‬ with a simulation study. The heritability ℎ ଶ , phenotypic correlation between parents ߩ , the population disease frequency ‫,ܭ‬ and corresponding threshold ܶ were defined as described in the main text. Hereby, the variance-covariance matrix of the genetic liabilities of the parents was defined as 4 The phenotypes ݈ of the siblings were than independently defined as
with ‫ܧ‬ ௦ randomly drawn from ܰ(0,1 − ℎ ଶ ). To conclude, the genetic liability of the complement ܿ1 of the first sibling ‫1ݏ‬ was defined as ‫ܩ‬ ଵ = ‫ܩ‬ + ‫ܩ‬ − ‫ܩ‬ ௦ଵ . In this manner, ݈ ௦ଵ , ‫ܩ‬ ௦ଵ , ݈ ௦ଶ , ‫ܩ‬ ௦ଶ , ‫ܩ‬ , ‫ܩ‬ and ‫ܩ‬ ଵ were defined for 10 ଼ families. We note that the value of ߪ ଶ ‫ܩ(‬ ௦ ) thus simulated was in line with previous theoretical
The respective variances, covariances and means were estimated from this simulation study and were in line with the theoretically derived values (see Table S3 ). Simulations were performed in R.
6 To formally get from the ‫)ܩ(ܧ‬ (Table S3 ) of cases and controls to the SNP-heritability ℎ ଶ that would be assessed is non-trivial, because no normal distribution thresholds exist to define the pseudocontrols or the probands with an additional affected sibling (which form a non-random subset of all cases not defined by a specific threshold). ℎ ଶ was therefore heuristically derived and validated with a simulation study of individual level SNP-data. In short, for any baseline disease frequency ‫,ܭ‬ a unique set of ܶ, ‫,ݖ‬ and ݅ can be found such that ‫ܭ‬ equals ܲ(݈ > ܶ|݈~ܰ(0,1)), ‫ݖ‬ the height of the standard normal distribution at ܶ, and ݅ = ‫ܭ/ݖ‬ the mean ݈ of cases, which results in a mean ‫ܩ‬ in cases of ݅ℎ ଶ . We numerically inverted this equation in R to find an unique equivalent-‫ܭ‬ matching the difference between
The equivalent-‫,ܭ‬ corresponding equivalent-‫ݖ‬ and Equation 3 yields the heritability that would be assessed with Haseman-Elston regression (Pred. ℎ ଶ ), and was validated with simulation study:
1. Following Golan et al, 1 the MAFs of 10,000 SNPs in full linkage disequilibrium were randomly sampled from ܷ[0.05,0.5], and the effect sizes were randomly sampled from ܰ(0, ℎ ଶ 10,000 ⁄ ).
2. 6. Unaffected Kid-1's were selected as screened controls.
7.
Step 2-6 were repeated until 2,000 cases and 2,000 screened controls were collected Legend to Table S5 .
We checked the analytical estimations (described in Supplemental Methods) of allele frequencies with a simulation study. Genotypes were simulated by first randomly assigning each parent two alleles with frequency ‫‬ = ‫)ܤ(ܲ‬ of the risk allele ‫.ܤ‬ Then, genotypes of the first and second siblings were defined by assigning them a single random allele from both of their parents. The genotypes of the pseudocontrols were defined as the two alleles of the parents not transmitted to the first sibling. Disease status was randomly assigned to parents, siblings, with a probability of disease per genotype of ܲ(Disease|Genotype) (see Witte et al for details) 7 . Families with the first sibling affected were selected as proband families with the first sibling serving as the proband case.
Assortative mating was simulated as the non-random mating fraction ߙ = 0.3 (see Supplemental Methods section 2.4 for details), which correspond to a spouse-correlation at the locus of 0.3 (note that this unrealistic large value is merely to validate theory, because assortative mating will have no impact on allele frequency as for a phenotypic spouse-correlation of 0.3 a locus explaining 1% of variance would have a spouse-correlation of only 0.3 * 0.01 = 0.003).
We simulated 10 ଼ families and compared allele frequencies in different types of cases, controls, and pseudocontrols to the algebraic estimates. Results displayed in this Table validate the analytical estimations described in the Supplemental Methods that were used to make the relevant Figures and Tables.
Supplemental Methods

Derivation of genetic liabilities in trio design
The mean genetic liabilities (breeding values) ‫)ܩ(ܧ‬ and their variances were subsequently derived for random families (Section 1.1), families with one affected sibling (Section 1.2), and families with two affected siblings (Section 1.3). Therefore, variance-covariance matrices were derived for these family's phenotypic liabilities and genetic liabilities. The mean genetic liability of screened controls in the offspring generation was derived in Section 1.4. The analytical estimates of the mean genetic liabilities and their variances were validated with a simulation study (Table S3 ). In Table S4 , the derived mean genetic liabilities are used to heuristically predict the SNP-based heritability that would be assessed with Haseman Elston-regression, which is again validated with a simulation study.
Consider a complex disease with a population frequency ‫ܭ‬ and heritability ℎ ଶ in the parental population. Define phenotype ݈ to represent the underlying liability for disease with variance ܸ = 1 (the choice for ܸ is arbitrary, but conveniently set to 1). The variance of genetic liabilities ‫ܩ‬ equals 
Variances and covariances of genetic liabilities in random families
Consider families with a mother (݉), father (݂), first sibling ‫,)1ݏ(‬ second sibling ‫)2ݏ(‬ and the pseudocontrol of the first sibling (interchangeably referred to as the complement of the first sibling, ܿ1). 
Variances and covariances of genetic liabilities in families with at least one affected sibling
Assortative mating increases the variances of the phenotype ݈ from the parental to the offspring generation with and ܻ represent all pairwise combinations of ݈ ௦ଵ , ‫ܩ‬ ௦ଵ , ݈ ௦ଶ , ‫ܩ‬ ௦ଶ , ‫ܩ‬ , ‫ܩ‬ and ‫ܩ‬ ଵ . 9 By this, all element are defined of ∑൫݈ ௦ଵ , ‫ܩ‬ ௦ଵ , ݈ ௦ଶ , ‫ܩ‬ ௦ଶ , ‫ܩ‬ , ‫ܩ‬ , ‫ܩ‬ ଵ ห ‫1ݏ‬ ‫,)݀݁ݐ݂݂ܿ݁ܽ‬ the 7x7 variance-covariance matrix of families with one affected sibling. Given these variances and covariances, the means were derived as follows.
• ‫݈(ܧ‬ ௦ଵ ‫1ݏ|‬ ݂݂ܽ) = ݅ ௦ ඥߪ ଶ (݈ ௦ )
following from the parents contribution
• ‫ܩ(ܧ‬ ଵ ‫1ݏ|‬ ݂݂ܽ) = ‫ܩ(ܧ‬ ‫1ݏ|‬ ݂݂ܽ) + ‫ܩ‪൫‬ܧ‬ ห‫1ݏ‬ ݂݂ܽ൯ − ‫ܩ(ܧ‬ ௦ଵ ‫1ݏ|‬ ݂݂ܽ)
Variances and covariances of genetic liabilities in families with two affected siblings
To derive variances and covariances within families with two affected siblings, we take the estimates of families with one affected sibling as starting point. However, in order to apply Tallis' method to account of reduction in variance when selecting for an affected sibling, ‫ܩ‬ and ݈ need to be normally distributed in all family members. The distribution of ݈ in the first sibling ‫1ݏ‬ is evidentially non-normal, because he is affected. Nevertheless, the distributions of ‫ܩ‬ and ݈ in the other family members are approximately normally distributed, which was illustrated by simulation (not shown) and can be intuitively understood as follows. The first sibling is affected when ݈ ௦ଵ exceeds the threshold ܶ.
However, because ݈ ௦ଵ is the sum of ‫ܩ‬ ௦ଵ and ‫ܧ‬ ௦ଵ and because ‫ܩ‬ ௦ଵ and ‫ܧ‬ ௦ଵ are independent, the violation of normality in ‫ܩ‬ ௦ଵ|௦ଵ is less than in ݈ ௦ଵ|௦ଵ . In addition, the covariances between ‫ܩ‬ ௦ଵ|௦ଵ
and ‫ܩ‬ and ݈ in the other family members are considerably smaller than 1. Hence, the distribution of ‫ܩ‬ and ݈ in all family members but sibling ‫1ݏ‬ are approximately normally distributed. Furthermore, note that the first and second sibling have equal genetic characteristics when they are both selected to be 
variance-covariance matrix of families with two affected siblings (leaving out the first sibling ‫.)1ݏ‬ Given this variance-covariance matrix, the means were derived as:
•
where
Genetic liabilities of screened controls
Screened controls were selected from the offspring generation, i.e. after one generation of assortative mating. In order to apply the useful properties of the standard normal distribution, the liability scale was inverted to regard controls as 'cases', and later transformed back to the original scale of ݈ in the parental generation. The population frequency of screened controls in the offspring generation is ‫ܭ‬ ௦ௗ ௧௦ = 1 − ‫ܭ‬ ௦ , which gives ݅ ௦ௗ ௧௦ and ݇ ௦ௗ ௧௦ as described previously in Section 1.2. The variation of genetic liabilities follows as
, and the mean as ‫ܩ(
, where the term is multiplied by −1 to transform the mean back to the original parental liability scale of ݈.
Derivation of a single SNP's risk allele frequency in trio design
First, the risk allele frequencies were analytically derived for screened controls, cases, and cases with unaffected parents ('cases' and 'probands' are used interchangeably) (Section 2.1). Second, risk allele frequencies were derived for cases with affected siblings by applying the first set of derived frequencies and by considering IBD-sharing between cases and their siblings (Section 2.2). Third, all acquired estimates were applied to estimate risk allele frequencies in pseudocontrols (Section 2.3).
Next we consider the impact of assortative mating (Section 2.4). To conclude, analytical derivations were validated with a simulation study (Table S5) .
Risk allele frequencies in screened controls, cases, and cases with unaffected parents
This Section closely follows the work of Witte et al. 
Risk allele frequencies in proband with an affected sibling
To estimate the risk allele frequency in cases (proband) with affected siblings, the combined probabilities of genotypes in cases and their siblings is required: given ‫ܩ‬ , and ‫ݍ‬ ே்|ீ = 1 − ‫‬ |ீ the frequency of ܾ. Note that ‫‬ ே்|ீ equals ‫‬ ௧௦ when the parental generation is in HWE, however when the parents are unaffected they are not in HWE and derivation of ‫‬ ே்|ீ is slightly more elaborate (described in Appendix A). When IBD=0, the genotypes ‫ܩ‬ ௦ depend on the distribution of the non-transmitted genotypes, which is also described in Appendix A. In this manner, the four matrices ‫ܩ(‬ ௦ | ‫ܩ‬ , ‫)ܦܤܫ‬ are defined as: 
Assortative mating
The impact of assortative mating on a single locus is expressed as the non-random mating fraction ߙ of parents with similar genotypes. The next generation has the following frequencies 
